Evidence map›Paper›PMID 36190991›Full record

ArticlePLoS computational biology2022

A fibrin enhanced thrombosis model for medical devices operating at low shear regimes or large surface areas.

Rodrigo Méndez Rojano, Angela Lai, Mansur Zhussupbekov, Greg W Burgreen, Keith Cook, James F Antaki

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rodrigo Méndez RojanoMeinig School of Biomedical Engineering, Cornell University, Ithaca, New York, United States of America.ORCID 0000-0001-6190-1628
Angela LaiDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.
Mansur ZhussupbekovMeinig School of Biomedical Engineering, Cornell University, Ithaca, New York, United States of America.ORCID 0000-0001-8806-2940
Greg W BurgreenCenter for Advanced Vehicular Systems, Mississippi State University, Starkville, Mississippi, United States of America.
Keith CookDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0002-5604-3718
James F AntakiMeinig School of Biomedical Engineering, Cornell University, Ithaca, New York, United States of America.
Cornell University · USCarnegie Mellon University · USMississippi State University · US

Funding

Multiscale Model of Thrombosis in Artificial CirculationR01HL089456 · NHLBI · CORNELL UNIVERSITY · PI ANTAKI, JAMES F., BUTCHER, JONATHAN TALBOT · 2009 to 2024
$8.5M
Identifying and Facilitating Ventricular Recovery on Mechanical SupportR01HL086918 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GORCSAN, JOHN · 2007 to 2011
$3.8M
NHLBI NIH HHS R01 HL086918NHLBI NIH HHS R01 HL089456
6 · The paper itself

Abstract

Over the past decade, much of the development of computational models of device-related thrombosis has focused on platelet activity. While those models have been successful in predicting thrombus formation in medical devices operating at high shear rates (> 5000 s-1), they cannot be directly applied to low-shear devices, such as blood oxygenators and catheters, where emerging information suggest that fibrin formation is the predominant mechanism of clotting and platelet activity plays a secondary role. In the current work, we augment an existing platelet-based model of thrombosis with a partial model of the coagulation cascade that includes contact activation of factor XII and fibrin production. To calibrate the model, we simulate a backward-facing-step flow channel that has been extensively characterized in-vitro. Next, we perform blood perfusion experiments through a microfluidic chamber mimicking a hollow fiber membrane oxygenator and validate the model against these observations. The simulation results closely match the time evolution of the thrombus height and length in the backward-facing-step experiment. Application of the model to the microfluidic hollow fiber bundle chamber capture both gross features such as the increasing clotting trend towards the outlet of the chamber, as well as finer local features such as the structure of fibrin around individual hollow fibers. Our results are in line with recent findings that suggest fibrin production, through contact activation of factor XII, drives the thrombus formation in medical devices operating at low shear rates with large surface area to volume ratios.

Indexed as

FibrinThrombosisBlood CoagulationBlood PlateletsFactor XIIHumansFactor XIIFibrin

Identifiers

PMID36190991
PMCPMC9560616
OpenAlexW4300690922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.